6-bromo-1H-pyridin-2-one

We are 6-bromo-1H-pyridin-2-one CAS:27992-32-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:6-bromo-1H-pyridin-2-one
CAS.NO:27992-32-1
Synonyms:6-bromo-2-pyridone; 6-Bromo-2-pyridinol; 6-Bromo-2(1H)-pyridinone; 6-bromopyridin-2-ol; 2-Bromo-6-Hydroxypyridine;
Molecular Formula:C5H4BrNO
Molecular Weight:173.99500
 
Physical and Chemical Properties:
Density:1.776;
Boiling point:336.6oC;
Flash point:157.4oC;
Index of Refraction:1.6;
 
Specification:
Appearance:Off-white  powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis

6-bromo-1H-pyridin-2-one


Related News: In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank.4-CHLORO-α-(METHYLAMINO)BENZENE ACETIC ACID CAS:143209-97-6 However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them.Chloro(chloromethyl)dimethylsilane The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.trans-4-Cyclohexyl-L-proline hydrochloride As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
Fmoc-Oic-OH View Details
ethyl 2-imidazo[1,2-a]pyridin-3-ylacetate View Details
Triptorelin acetate View Details
Pyruvonitril manufacturer 4-Chlorobenzotrifluoride manufacturer perfluoro-n-butane sulfonamide Cas:30334-69-1 manufacturer 1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride manufacturer 1,1,1-Trifluoroethane Cas:420-46-2 manufacturer